D. Phil, Chief Technology Officer, Biodesix
Dr. Röder is a company founder and author or co-author of more than 100 publications/talks in theoretical physics and computational sciences. Dr. Röder obtained his D.Phil at Oxford University, and went on to become an eminent theoretical physicist with positions at University of Hanover and Bayreuth (Germany) and Los Alamos National Laboratory. He has led projects involving the diagonalization of gigadimensional matrices, has done pioneering work in the microscopic mechanisms of colossal magneto resistive perovskites, and initiated the first use of large-scale inverse problem techniques in the analysis of neutron scattering data. Recruited from Los Alamos, Dr. Röder serves as Biodesix’ CTO, leading the Research and Development side of the Company and designing functionality for next generation products and services. Dr. Röder is a Rhodes Scholar.
Presentation Title and Company Description
AI and Data Science Showcase: Applied Machine Learning for Immuno-Oncology Diagnostics
Biodesix® is a molecular diagnostics company advancing the development of innovative, multi-omic blood tests in oncology to enable precision medicine. Biodesix uses applied machine learning to develop diagnostic tests that identify patients who may benefit from immunotherapies.